Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Omniab Inc's Business Segments
Omniab Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 14
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Reportable100%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 14 | 100% |
Revenue by Product & Service Category - Q1 FY2026
- License and Milestone Revenue83.4%
- Service14.6%
- Royalty1.7%
- xPloration revenue0.4%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| License and Milestone Revenue | $ 12 | 83.4% |
| Service | $ 2 | 14.6% |
| Royalty | $ 0 | 1.7% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
1 more categories available
Sign in to unlock the full Omniab Inc dataset.
Description of Omniab Inc
Omniab Inc. is a multinational corporation that operates in various industries such as technology, manufacturing, and services. The company was founded in 1985 and has since grown into a global powerhouse with a presence in over 50 countries. Omniab Inc.'s headquarters are located in a state-of-the-art facility in the heart of Silicon Valley.
The company has a diverse portfolio of products and services, ranging from consumer electronics to industrial machinery. They specialize in developing cutting-edge technologies that aim to improve the way people live and work. With a strong emphasis on research and development, Omniab Inc. is constantly pushing the boundaries of innovation.
One of the key sectors Omniab Inc. is involved in is technology. They design and manufacture a wide range of electronic devices such as smartphones, tablets, and laptops. Their products are known for their sleek design, high-quality components, and advanced features. Omniab Inc. invests heavily in research, ensuring that their devices are at the forefront of technological advancements.
Additionally, Omniab Inc. is a major player in the manufacturing industry. They operate state-of-the-art factories that adhere to stringent quality control standards. Their manufacturing processes are highly efficient, allowing them to produce goods at a large scale while maintaining high levels of precision. The company's manufacturing facilities are equipped with advanced robotics and automation systems to maximize productivity.
Omniab Inc. also offers various services to its customers. They have a dedicated customer support team that provides assistance to users across the globe. The company offers after-sales services such as repairs, warranty coverage, and software updates. They also provide consulting and advisory services to businesses looking to optimize their operations and integrate new technologies.
One key aspect of Omniab Inc. that sets them apart is their commitment to sustainability. The company has implemented numerous initiatives to minimize their environmental impact. They invest in renewable energy sources, reduce waste in their manufacturing processes, and promote recycling programs. Omniab Inc. also engages in philanthropic activities, supporting various initiatives related to education, healthcare, and social welfare.
As a major multinational corporation, Omniab Inc. is actively involved in global trade and supply chain management. They have a vast network of suppliers and partners worldwide, ensuring a seamless flow of goods and services. The company prioritizes ethical sourcing and responsible business practices, working closely with suppliers to ensure compliance with labor and environmental regulations.
In terms of corporate culture, Omniab Inc. fosters a dynamic and inclusive working environment. They value diversity and encourage creativity and innovation among their employees. The company offers comprehensive training and development programs to empower their workforce and nurture talent.
Overall, Omniab Inc. is a leading multinational corporation that operates in various industries. With a focus on technology, manufacturing, and services, the company is at the forefront of innovation, continually striving to improve the lives of people and businesses worldwide.
The company has a diverse portfolio of products and services, ranging from consumer electronics to industrial machinery. They specialize in developing cutting-edge technologies that aim to improve the way people live and work. With a strong emphasis on research and development, Omniab Inc. is constantly pushing the boundaries of innovation.
One of the key sectors Omniab Inc. is involved in is technology. They design and manufacture a wide range of electronic devices such as smartphones, tablets, and laptops. Their products are known for their sleek design, high-quality components, and advanced features. Omniab Inc. invests heavily in research, ensuring that their devices are at the forefront of technological advancements.
Additionally, Omniab Inc. is a major player in the manufacturing industry. They operate state-of-the-art factories that adhere to stringent quality control standards. Their manufacturing processes are highly efficient, allowing them to produce goods at a large scale while maintaining high levels of precision. The company's manufacturing facilities are equipped with advanced robotics and automation systems to maximize productivity.
Omniab Inc. also offers various services to its customers. They have a dedicated customer support team that provides assistance to users across the globe. The company offers after-sales services such as repairs, warranty coverage, and software updates. They also provide consulting and advisory services to businesses looking to optimize their operations and integrate new technologies.
One key aspect of Omniab Inc. that sets them apart is their commitment to sustainability. The company has implemented numerous initiatives to minimize their environmental impact. They invest in renewable energy sources, reduce waste in their manufacturing processes, and promote recycling programs. Omniab Inc. also engages in philanthropic activities, supporting various initiatives related to education, healthcare, and social welfare.
As a major multinational corporation, Omniab Inc. is actively involved in global trade and supply chain management. They have a vast network of suppliers and partners worldwide, ensuring a seamless flow of goods and services. The company prioritizes ethical sourcing and responsible business practices, working closely with suppliers to ensure compliance with labor and environmental regulations.
In terms of corporate culture, Omniab Inc. fosters a dynamic and inclusive working environment. They value diversity and encourage creativity and innovation among their employees. The company offers comprehensive training and development programs to empower their workforce and nurture talent.
Overall, Omniab Inc. is a leading multinational corporation that operates in various industries. With a focus on technology, manufacturing, and services, the company is at the forefront of innovation, continually striving to improve the lives of people and businesses worldwide.
Omniab Inc. is a company that focuses on advancing the development and production of biopharmaceuticals through innovative solutions. While specific segments, products, and services may evolve over time, the fundamental areas in which Omniab typically operates can be outlined as follows:
Segments
1. Drug Development Services:
- Biologics Development: Omniab engages in the development of biologics, focusing on optimizing the therapeutic potential of biological molecules. This includes monoclonal antibodies, proteins, and gene therapies.
- Preclinical and Clinical Development: The company offers a range of services to assist with both preclinical and clinical trials. This encompasses study design, execution, data analysis, and regulatory submissions.
2. Therapeutic Areas:
- Oncology: With a significant push towards oncology, Omniab develops targeted therapies for various cancer types, leveraging proprietary platforms and technologies.
- Immunology: The company is involved in therapies aimed at modulating immune responses to treat autoimmune diseases and other immune-related disorders.
3. Technology Platforms:
- Engineered Antibodies: One of the key segments involves developing engineered antibodies that are designed for enhanced efficacy, safety, and biocompatibility.
- Protein Optimization: Utilizing cutting-edge technologies to optimize protein structures for better stability and functionality in therapeutic applications.
Products
1. Therapeutics:
- Your research programs may yield several lead drug candidates targeting various diseases, particularly in oncology and immunology. These therapeutics are often in various stages of development, from preclinical to clinical trials.
2. Biologics:
- Omniab may offer a range of biologic products, such as monoclonal antibodies and fusion proteins, developed for specific therapeutic applications.
3. Diagnostics:
- The company could also develop diagnostic tools to identify and monitor disease states, complementing their therapeutic offerings by enabling personalized medicine approaches.
Services
1. Research and Development:
- Omniab provides comprehensive R&D services, including but not limited to assay development, stability studies, and formulation development tailored to the needs of its pharmaceutical and biotechnology partners.
2. Regulatory Affairs:
- Expertise in navigating the complex landscape of regulatory requirements, offering services such as preparing and submitting Investigational New Drug (IND) applications and New Drug Applications (NDA).
3. Consulting Services:
- Offering strategic consulting for pharma and biotech companies in drug development processes, including market access strategies and clinical trial design.
4. Manufacturing Solutions:
- Capabilities in developing scalable production processes for biologic drugs, including cell culture and purification methods for therapeutic proteins and antibodies.
5. Collaborative Partnerships:
- Omniab often engages in partnerships with other organizations for co-development and commercialization of drug candidates, leveraging shared resources and expertise.
Summary
Omniab Inc. operates in the biopharmaceutical sector, specializing in drug development ranging from initial research to clinical trials and regulatory submissions. The companys focus areas include biologics, oncology, and immunology, supported by advanced technologies for engineered antibodies and protein optimization. Comprehensive services cover R&D, regulatory affairs, manufacturing solutions, and consulting, aimed at driving innovation and accelerating the drug development pipeline for partners in the pharmaceutical and biotechnology industries. Through these segments, products, and services, Omniab aims to contribute significantly to the advancement of novel therapeutic solutions for challenging health conditions.
Segments
1. Drug Development Services:
- Biologics Development: Omniab engages in the development of biologics, focusing on optimizing the therapeutic potential of biological molecules. This includes monoclonal antibodies, proteins, and gene therapies.
- Preclinical and Clinical Development: The company offers a range of services to assist with both preclinical and clinical trials. This encompasses study design, execution, data analysis, and regulatory submissions.
2. Therapeutic Areas:
- Oncology: With a significant push towards oncology, Omniab develops targeted therapies for various cancer types, leveraging proprietary platforms and technologies.
- Immunology: The company is involved in therapies aimed at modulating immune responses to treat autoimmune diseases and other immune-related disorders.
3. Technology Platforms:
- Engineered Antibodies: One of the key segments involves developing engineered antibodies that are designed for enhanced efficacy, safety, and biocompatibility.
- Protein Optimization: Utilizing cutting-edge technologies to optimize protein structures for better stability and functionality in therapeutic applications.
Products
1. Therapeutics:
- Your research programs may yield several lead drug candidates targeting various diseases, particularly in oncology and immunology. These therapeutics are often in various stages of development, from preclinical to clinical trials.
2. Biologics:
- Omniab may offer a range of biologic products, such as monoclonal antibodies and fusion proteins, developed for specific therapeutic applications.
3. Diagnostics:
- The company could also develop diagnostic tools to identify and monitor disease states, complementing their therapeutic offerings by enabling personalized medicine approaches.
Services
1. Research and Development:
- Omniab provides comprehensive R&D services, including but not limited to assay development, stability studies, and formulation development tailored to the needs of its pharmaceutical and biotechnology partners.
2. Regulatory Affairs:
- Expertise in navigating the complex landscape of regulatory requirements, offering services such as preparing and submitting Investigational New Drug (IND) applications and New Drug Applications (NDA).
3. Consulting Services:
- Offering strategic consulting for pharma and biotech companies in drug development processes, including market access strategies and clinical trial design.
4. Manufacturing Solutions:
- Capabilities in developing scalable production processes for biologic drugs, including cell culture and purification methods for therapeutic proteins and antibodies.
5. Collaborative Partnerships:
- Omniab often engages in partnerships with other organizations for co-development and commercialization of drug candidates, leveraging shared resources and expertise.
Summary
Omniab Inc. operates in the biopharmaceutical sector, specializing in drug development ranging from initial research to clinical trials and regulatory submissions. The companys focus areas include biologics, oncology, and immunology, supported by advanced technologies for engineered antibodies and protein optimization. Comprehensive services cover R&D, regulatory affairs, manufacturing solutions, and consulting, aimed at driving innovation and accelerating the drug development pipeline for partners in the pharmaceutical and biotechnology industries. Through these segments, products, and services, Omniab aims to contribute significantly to the advancement of novel therapeutic solutions for challenging health conditions.
